Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.21.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Current assets    
Cash and cash equivalents $ 36,477 $ 72,256
Restricted cash 763 154
Short-term deposits 19,851 10,003
Related parties 50
Other current assets 3,576 2,068
Total current assets 60,667 84,531
Non-current assets    
Lease deposit 5
Operating lease right-of-use asset 4,430 1,148
Property and equipment, net 2,228 1,881
In-process research and development ("R&D") 3,038 4,556
Total non-current assets 9,696 7,590
Total asset 70,363 92,121
Current liabilities    
Trade account payables 2,320 3,253
Current portion of lease liabilities 863 375
Other account payables 3,978 2,596
Total current liabilities 7,161 6,224
Non-current liabilities    
Lease liabilities, net of current portion 5,032 856
Contingent liabilities 701 585
Total non-current liabilities 5,733 1,441
Commitments and Contingent Liabilities
Stockholders' equity    
Common stock, $0.0001 par value ("Common Stock"); Authorized - 60,000,000 shares as of December 31, 2020 and 2019. Issued - 23,270,337 and 22,862,835 as of December 31,2020 and 2019, respectively. Outstanding - 23,264,637 and 22,862,835 as of December 31, 2020 and 2019, respectively. 2 2
Additional paid in capital 129,725 126,626
Accumulated deficit (72,258) (42,172)
Total Stockholders' equity 57,469 84,456
Total liabilities and stockholders' equity $ 70,363 $ 92,121